After 15 years as General Partner, Holger transitioned to the role of Senior Advisor on April 1, 2025. He joined Forbion in 2010, where he established the Munich office and played a key role in building its local team. As a member of the investment team, he was actively involved in deals across biopharma, medical devices, and diagnostics.
In addition to his role at Forbion, Holger serves on the investment committee of High-Tech Gründerfonds, Germany’s largest early-stage and seed investor. He also co-leads the Tax & Finance working group at BIO Deutschland, the leading industry association representing the German biotechnology sector.
We partner with innovation-driven entrepreneurs to build successful businesses.
Portfolio
Companies worked on by Holger Reithinger
